This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Bial Industrial Farmaceutica, S.a.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Maria Carmen Arilla Rodriguez: Innovator in Allergy Treatment
Introduction: Maria Carmen Arilla Rodriguez, based in Bilbao, Spain, is an accomplished inventor known for her significant contributions to the field of allergy treatment. With a patent to her name, she focuses on innovative solutions aimed at improving the lives of those affected by allergies, particularly those caused by mite exposure.
Latest Patents: Maria's sole patent is titled "Hypoallergenic hybrid proteins of major group 1 and 2 mite allergens for use in the treatment of allergies." This groundbreaking invention pertains to recombinant DNA molecules that encode hybrid polypeptides derived from different allergens beneficial for allergy prevention and treatment. The invention specifically focuses on hybrid proteins that incorporate fragments of allergens Derp p 1 and Derp p 2, which possess hypoallergenic characteristics while retaining their immunogenic capacity. This makes them especially valuable for treating allergy sufferers. Moreover, Maria's patent outlines the production methods for these polypeptides in heterologous expression systems and efficient purification techniques for the hybrid proteins.
Career Highlights: Maria Carmen Arilla Rodriguez is employed at Bial Industrial Farmaceutica S.A., where she has been integral to developing innovative biomedical solutions. Her work has not only advanced the understanding of allergens but also provided new avenues for therapeutic interventions.
Collaborations: Throughout her career, Maria has collaborated with esteemed colleagues such as Juan Andrés Asturias Ortega and Iñaki Ibarrola Lopez De Davalillo. These collaborations have been essential in furthering research and development within her field, fostering a team-oriented atmosphere that promotes innovation.
Conclusion: Maria Carmen Arilla Rodriguez exemplifies the spirit of innovation in the fight against allergies. Her patented work on hypoallergenic hybrid proteins marks a significant stride in allergy treatment, showcasing her dedication and expertise. With continued collaboration and research, Maria's contributions hold the potential to enhance the quality of life for allergy sufferers worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile